Skip to main content
Delivra Health Brands Inc. logo

Delivra Health Brands Inc. — Investor Relations & Filings

Ticker · DHB TSXV Manufacturing
Filings indexed 156 across all filing types
Latest filing 2025-05-21 Interim / Quarterly Rep…
Country CA Canada
Listing TSXV DHB

About Delivra Health Brands Inc.

https://www.delivrahealthbrands.com/

Delivra Health Brands Inc. operates as a Consumer Packaged Goods (CPG) company focused on the health and wellness sector. The firm specializes in developing and distributing premium, science-backed, alternative self-care solutions designed to address prevalent everyday issues, including chronic pain, anxiety, and sleeplessness. Key brands within its portfolio include Dream Water®, which provides various formats of sleep support products such as liquid shots, gummies, and powder packets, and LivRelief™, which offers topical pain relief creams. Delivra Health aims to enhance the quality of life for consumers globally by providing effective alternatives when traditional remedies prove insufficient.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Condensed Consolidated Interim Financial Statements (Unaudited)' for Delivra Health Brands Inc. for the three and nine months ended March 31, 2025. It contains comprehensive financial statements (position, loss, equity, cash flows) and detailed notes to the financial statements. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. Q1 2025
2025-05-21 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing a product launch into new markets. It is not an earnings release, financial report, management discussion, change in board or financing activity, nor a regulatory or legal notice with specific thresholds or directives. It is a general corporate news announcement, best fitting the fallback category of Regulatory Filings (RNS).
2025-05-08 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing a new product launch (Dream Water® 6-Count Sleep Gummies) and contains forward-looking statements. It does not present financial results, voting items, regulatory filings, or other specific report types. There is no indication of an annual or quarterly report, earnings release, management discussion & analysis, or any other category in the provided taxonomy. Therefore, it falls into the general fallback category for miscellaneous regulatory announcements.
2025-03-12 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release announcing the company’s second quarter fiscal 2025 financial and operating results, including revenue, profitability metrics, and management commentary. It provides key highlights for the quarter and first half of the fiscal year, typical of an earnings release. It is not the full interim report (which would be longer and more detailed), but rather the initial quarterly results announcement. Therefore, it is classified as an Earnings Release. Q2 2025
2025-02-27 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” by the CEO under National Instrument 52-109 for a venture issuer. It is not the interim financial report or MD&A itself, nor an announcement of dividends, dividends or capital changes, but rather a regulatory compliance certificate. It does not fit any other specific category, so it falls under the general “Regulatory Filings” fallback category.
2025-02-27 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a NI 52-109 Form 52-109FV2 “Certification of Interim Filings” by the CFO of a Canadian venture issuer certifying the completeness and fair presentation of the interim financial report and interim MD&A for the period ended December 31, 2024. It is neither the interim report itself (IR), nor a management discussion report (MDA), nor an audit report (AR), but rather a regulatory certification form required by securities legislation. No specific category exists for certification forms, so it falls under the fallback category for miscellaneous regulatory filings (RNS).
2025-02-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.